A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses-Reference-Cited by-同舟云学术

A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses

Published:2010-12 Issue:13 Volume:32 Page:2186-2197
ISSN:0149-2918
Container-title:Clinical Therapeutics
language:en
Short-container-title:Clinical Therapeutics

Author:

Beran Jiri,Abdel-Messih Ibrahim A.,Raupachova Jolana,Hobzova Lenka,Fragapane Elena

Publisher

Elsevier BV

Subject

Pharmacology (medical),Pharmacology

Reference33 articles.

1. Establishment of multiple sublineages of H5N1 influenza virus in Asia: Implications for pandemic control;Chen;Proc Natl Acad Sci U S A,2006

2. How prepared is Europe for pandemic influenza? Analysis of national plans;Mounier-Jack;Lancet,2006

3. Vaccines against avian influenza—a race against time;Poland;N Engl J Med.,2006

4. Avian influenza vaccines: What's all the flap?;Sambhara;Lancet,2006

5. Influenza pandemic preparedness: Gauging from EU plans;Shortridge;Lancet,2006

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune Control of Avian Influenza Virus Infection and Its Vaccine Development;Vaccines;2023-03-04

2. Determination of the frequency of influenza-A and B antigens in swab samples in differentiating the diagnosis of influenza infection from other causes of upper respiratory tract infection;Journal of Health Sciences and Medicine;2023-01-12

3. Analyses of Safety Profile and Homologous Antibody Responses to a Mammalian Cell-Based, MF59-Adjuvanted, A/H5N1, Pandemic Influenza Vaccine across Four Phase II/III Clinical Trials in Healthy Children, Adults, and Older Adults;Vaccines;2021-12-11

4. Cross-Reactivity Conferred by Homologous and Heterologous Prime-Boost A/H5 Influenza Vaccination Strategies in Humans: A Literature Review;Vaccines;2021-12-10

5. Adjuvant‐mediated enhancement of the immune response to HIV vaccines;The FEBS Journal;2021-03-23